Valuation check: MKD's profit margin is -1.47%, below the Industrials sector average of 10.14%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2020
Trailing 12 months ending Dec 2020
Molecular Data (MKD) currently reports a profit margin of -1.47% as of December 2020. That is below the Industrials sector average of 10.14%. Use the charts on this page to explore Molecular Data's profit margin history and peer comparisons.
Molecular Data's profit margin of -1.47% is lower than the Industrials sector average of 10.14%. That is roughly 114.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Molecular Data's current -1.47% should be judged against Industrials norms (sector average: 10.14%) and against MKD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -1.47%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 10.14%. From there, open related valuation or income-statement pages for Molecular Data, and consider following MKD for alerts when major investors trade the stock.
Molecular Data is classified in the Industrials sector. On profit margin, it currently shows -1.47% versus a sector average near 10.14%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing MKD with unrelated industries.